Skip to content

Clinical trials

Phase 2 Myeloproliferative Disorders trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 2 Country / region: Italy Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20052
20071
20081
20111
20132
20142
20151
20171
20181
20201
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated3
Active, not recruiting2
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation4
Novartis Pharmaceuticals3
Fred Hutchinson Cancer Center2
Cogent Biosciences, Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
Hoffmann-La Roche1
Istituto Clinico Humanitas1
Italfarmaco1
John Mascarenhas1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders18
Leukemia, Myeloid, Acute7
Hematologic Diseases5
Primary Myelofibrosis5
Leukemia, Myeloid, Chronic-Phase4
Lymphoma, Non-Hodgkin4
Multiple Myeloma4
Polycythemia Vera4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Burkitt Lymphoma3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.